Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
European Journal of Nutrition
Published in: European Journal of Nutrition 4/2004

01-08-2004 | ORIGINAL CONTRIBUTION

Lyophilized carrot ingestion lowers lipemia and beneficially affects cholesterol metabolism in cholesterol–fed C57BL/6J mice

Authors: C. Nicolle, Ph.D, E. Gueux, C. Lab, L. Jaffrelo, E. Rock, A. Mazur, P. Amouroux, C. Rémésy

Published in: European Journal of Nutrition | Issue 4/2004

Login to get access
Metadata
Title
Lyophilized carrot ingestion lowers lipemia and beneficially affects cholesterol metabolism in cholesterol–fed C57BL/6J mice
Authors
C. Nicolle, Ph.D
E. Gueux
C. Lab
L. Jaffrelo
E. Rock
A. Mazur
P. Amouroux
C. Rémésy
Publication date
01-08-2004
Publisher
Steinkopff-Verlag
Published in
European Journal of Nutrition / Issue 4/2004
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-004-0465-3

Other articles of this Issue 4/2004

European Journal of Nutrition 4/2004 Go to the issue

ORIGINAL CONTRIBUTION

The potent in vitro antioxidant ellagitannins from pomegranate juice are metabolised into bioavailable but poor antioxidant hydroxy–6H–dibenzopyran–6– one derivatives by the colonic microflora of healthy humans

ORIGINAL CONTRIBUTION

Rye bran bread intake elevates urinary excretion of ferulic acid in humans, but does not affect the susceptibility of LDL to oxidation ex vivo

ORIGINAL CONTRIBUTION

Nutritional–pharmacological combinations

ORIGINAL CONTRIBUTION

In vitro starch digestibility and in vivo glucose response of gluten–free foods and their gluten counterparts

ORIGINAL CONTRIBUTION

Evaluation of xenobiotics in human milk and ingestion by the newborn

ORIGINAL CONTRIBUTION

Soymilk or progesterone for prevention of bone loss
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits